EvolveImmune Therapeutics Announces FDA Clearance of Investigational New Drug Application for EVOLVE104, a Novel Trispecific T Cell Engager with Integrated CD2 Costimulation GlobeNewswire August 14, 2025 First Program from EVOLVE T-Cell Engager Platform to Advance into Clinical Development Phase 1 Clinical Trial of EVOLVE104 to be Initiated in 2025 BRANFORD, Conn., Aug. 14, 2025 (GLOBE […]

Illinois-based Firm Adds to Existing Institutional Retirement Plan Consulting and Wealth Management Services SageView Advisory Group (“SageView”), one of the nation's leading independent RIA firms, announced today it has acquired CAP STRAT (Capital Strategies Investment Group LLC), an institutional retirement plan consulting and wealth management firm based in Oakbrook Terrace, Illinois. CAP STRAT manages approximately

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update Q2 2025 Net Product Sales Increased 47% Year-over-Year to $3.8 Million GlobeNewswire August 14, 2025 SOLANA BEACH, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis

The strongest business strategies today start with one thing: how people experience work. Semos Cloud, a global innovator in HR technology and employee experience platforms, launches HR Navigator, a curated bi-weekly newsletter designed for modern HR professionals navigating the complexity of today's workforce challenges. https://mma.prnewswire.com/media/2750508/Semos_Cloud_HR_Navigator.jpg HR Navigator is the executive briefing for building exceptional workplaces.

Lazydays Holdings, Inc. (NasdaqCM: GORV) (“Lazydays,” the “Company” or “we”) today reports financial results for the second quarter ended June30, 2025. https://mma.prnewswire.com/media/2652243/Lazydays_RV_Logo.jpg Ron Fleming, CEO, said, “We continued to advance our turnaround plan in the second quarter of 2025. Our focus on operational performance resulted in increases in gross profit margins across all products and

Today, Coalition for Health AI (CHAI), a nonprofit organization founded by clinicians to advance responsible health AI, and the National Association of Community Health Centers (NACHC), the leading association advocating for the nation's Community Health Centers (CHCs) and their nearly 34 million patients in communities nationwide, announced a new strategic partnership that will empower safe

Exclusivity agreement covers Corero's leading and innovative on-premises DDoS protection solutions, delivered through trusted partner Forte Technology Corero Network Security, (AIM: CNS) (OTCQX: DDOSF), a recognized leader in DDoS protection and champion of adaptive, real-time service availability, today announced an exclusive channel-reseller agreement appointing Forte Technology of America LLC as the sole authorized reseller of

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter of 2025. Leap Highlights: — Board of Directors initiated process of exploring strategic alternatives to maximize shareholder value — Strategic restructuring to prioritize corporate development resulting in a further 75% reduction in workforce

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire August 14, 2025 PITTSBURGH, Aug. 14, 2025 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, and CLIA laboratory to accelerate oncologic drug discovery and enable drug

After achieving the highest sales results for a six-month period ever in the company's history in the first half of 2025, Sentrycs, the premiere technology leader in cyber over RF solutions for counter-UAS (CUAS), announced it is on track to double its revenues in 2025. https://mma.prnewswire.com/media/2422730/5087617/Sentrycs_Logo.jpg Sentrycs Executive Chairman Howard Berkowitz commented on the midyear